Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Canadian Medtech Keeps An Eye On Transition To MDSAP; Regulator Won't Allow Grace Period

This article was originally published in SRA

Executive Summary

As Health Canada prepares to kick-start in 2017 its two-year plan to fully adopt the Medical Device Single Audit Program (MDSAP) in place of the current Canadian Medical Devices Conformity Assessment System (CMDCAS), the local medtech industry association MEDEC is upbeat about the change and says that while the transition plan may pose challenges, it believes it is too early to say what these might be1,2.

You may also be interested in...



Device Firms Invited To Join MDSAP Ahead Of 2017 Full Launch

Medical device firms are being invited to participate in the international single audit program, which will enter the operational phase next year.

Marketing Applications Continue To Fall In Canada, But MEDEC Expects Recovery Ahead

Health Canada has reported a drop in medical device submissions, but medical technology industry group MEDEC is not expecting the decline to continue in the long term.

Medical Device Regulations In Latin America And The Way Forward

Akhila Krishnan reviews the different regulatory requirements for medical devices in five Latin American countries and discusses how harmonization initiatives will make things easier for manufacturers in this guest column.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT040781

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel